BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GenTel BioSciences, Inc. Announces Agreement With Oregon Health & Science University (OHSU)


8/29/2011 8:51:16 AM

MADISON, WI--(Marketwire - August 29, 2011) -

Gentel Biosciences, a provider of animal health research products, announces today an agreement with Oregon Health & Science University (OHSU) to license viral antigens for use in Gentel's Colony Surveillance Assays (CSA).

Gentel licensed the viral antigens from OHSU for worldwide commercial use. These antigens were developed at the molecular virology core at OHSU's Oregon National Primate Research Center in Beaverton, Ore. The agreement was completed on August 9, 2011.

According to Dan Clutter, Gentel's Vice President of Commercial Development, "Gentel is committed to providing simple, low cost multiplex assays that allow researchers to maintain better colony health and thus obtain more meaningful data from their research. OHSU is a highly respected institution and incorporating their viral antigens into Gentel's CSA: Simian products enables us to offer a more valuable tool for non-human primate colony surveillance."

The addition of the viral antigens to the Colony Surveillance Assay product line complements Gentel's initiatives to grow its line of products to support translational research disease models. This strategy includes the addition the OHSU antigens to an expanded panel which covers additional opportunistic pathogens set to launch in early Fall 2011. The CSA: Simian Basic and the CSA: Simian Expanded products provide the foundation for Gentel's growing animal health research product line that enables exceptional diagnostic accuracy for serological screening of non-human primates (NHP).

More information at www.CSA-Simian.com

NHP models for disease are a critical component of translational research for disease models like HIV, an important model system for the human immune system and are often used in vaccine studies. Maintaining SPF status for these types of animal models is crucial to sustain the integrity of the study and prevent confounding results due to latent or opportunistic infections.

Gentel launched its product line supporting laboratory animal health in 2010 for non-human primates with its CSA: Simian Basic panel which includes 6 infectious agents monitored in SPF primates. The CSA: Simian Expanded panel includes the viral antigens from the ONPRC and covers an additional 5 infectious agents, for a total of 11 tests in one assay. The CSA products use the Gentel Proteomics Multi-System™, a complete analysis platform that integrates data capture and analysis at a price that is comparable to that of a bench-top ELISA system.

"Our main goal is to allow colony managers to get the lowest false positive/negative rates, in hours and at a significantly lower cost. Our second goal is to offer a broad enough selection of products that we can serve every NHP colony in the world. Working with OHSU helps us reach these goals," said Alex Vodenlich, Gentel President and CEO.

Moving discoveries made in the lab into the marketplace is one of OHSU's core missions. "OHSU has adopted the 'technology transfer 3.0' model where we treat each interaction as the start of a long-term relationship. We feel that this approach potentially benefits the company, the university and the faculty by creating a mechanism for long-term collaborations," said Arundeep S. Pradhan, associate vice president for technology transfer and business development at OHSU.

In the case of the Gentel licensing agreement, the product that is the end result of the commercialization effort will also help to advance research at OHSU, said Nancy Haigwood, Ph.D., director of the Oregon National Primate Research Center. "Having access to quick and reliable assays that are more affordable will positively impact the health of our colony and our research."

About Gentel Biosciences, Inc.
Gentel delivers cost-effective, easy-to-use and reliable products to support laboratory animal health. These research products are designed to work with the Gentel Proteomics Multi-System™ (GPM), an all-in-one instrument for data capture and analysis. Gentel also has a strong portfolio of research oriented products for cancer biomarkers, cytokines, and tumor protein analysis, which also work with the GPM. Gentel's headquarters is located in Madison, Wisconsin.

About OHSU
Oregon Health & Science University is the state's only health and research university, and only academic health center. As Portland's largest employer and the fourth largest in Oregon (excluding government), OHSU's size contributes to its ability to provide many services and community support activities not found anywhere else in the state. It serves more than 184,000 patients, and is a conduit for learning for more than 3,900 students and trainees. OHSU is the source of more than 200 community outreach programs that bring health and education services to each county in the state.


For More Information:
Dan Clutter, Ph.D.
Vice-President, Commercial Development
Gentel Biosciences, Inc.
Phone: 608-441-2904

Elisa Williams
Senior Communications Specialist
Oregon Health & Science University
Phone: 503 494-8231
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->